Crescita Therapeutics (Crescita Therapeutics) Days Sales Outstanding : 33.72 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Days Sales Outstanding?

Crescita Therapeutics's average Accounts Receivable for the three months ended in Dec. 2023 was $1.30 Mil. Crescita Therapeutics's Revenue for the three months ended in Dec. 2023 was $3.52 Mil. Hence, Crescita Therapeutics's Days Sales Outstanding for the three months ended in Dec. 2023 was 33.72.

The historical rank and industry rank for Crescita Therapeutics's Days Sales Outstanding or its related term are showing as below:

CRRTF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.6 Med: 60.67 Max: 353.79
Current: 66.43

During the past 10 years, Crescita Therapeutics's highest Days Sales Outstanding was 353.79. The lowest was 34.60. And the median was 60.67.

CRRTF's Days Sales Outstanding is ranked better than
55% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 72.34 vs CRRTF: 66.43

Crescita Therapeutics's Days Sales Outstanding declined from Dec. 2022 (61.95) to Dec. 2023 (33.72).

Crescita Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Crescita Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Days Sales Outstanding Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

60.62

40.13

34.59

52.73

59.30

Crescita Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															61.95	87.15	68.49	91.19	33.72

Competitive Comparison of Crescita Therapeutics's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Crescita Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Crescita Therapeutics's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Crescita Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Crescita Therapeutics's Days Sales Outstanding falls into.

Crescita Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Crescita Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3.357	+	0.887)	/	2 )	/	13.061	*	365
=	2.122					/	13.061	*	365
=	59.30

Crescita Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.716	+	0.887)	/	2 )	/	3.522	*	365 / 4
=	1.3015					/	3.522	*	365 / 4
=	33.72

Crescita Therapeutics (OTCPK:CRRTF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Crescita Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics (Crescita Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (OTCPK:CRRTF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

CTX:Canada

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.